Showing 41 - 50 of 901,942
the biotechnology field as an example, Giest highlights challenges in the collaborative efforts of public bodies, private …
Persistent link: https://www.econbiz.de/10012382214
This report examines examples of new and emerging governance models that aim to support the responsible development of diagnostics and treatments based on the latest advances in biomedicine. In particular, it presents programmes and initiatives that aim to manage uncertainty in the development...
Persistent link: https://www.econbiz.de/10011632331
enrich the conversation by sketching the situation in Europe and providing an interesting measure for comparison. In doing so … biotechnology sector, is built into the system over the years. Although the EPC was introduced as a unitary regulatory tool … law to the needs of distinct technology sectors, and in particular the biotechnology sector. Given the civil law tradition …
Persistent link: https://www.econbiz.de/10014188440
Persistent link: https://www.econbiz.de/10014581956
Persistent link: https://www.econbiz.de/10003851463
Persistent link: https://www.econbiz.de/10009487448
of commercial biotechnology in Germany. The current paper tries to fill this gap. We find that although these contests …
Persistent link: https://www.econbiz.de/10003761389
Persistent link: https://www.econbiz.de/10003750719
The German biotechnology industry missed the accession of this key technology in the 1980s. Policy makers make … biotech industry in Germany. We assume that R&D policy was driven blind by the idea to catch up with world’s biotech leaders … and analyse if Germany’s R&D policy lost its origins. We do examine, if Germany sacrifice economic funding principles, in …
Persistent link: https://www.econbiz.de/10003178532
Persistent link: https://www.econbiz.de/10002102990